• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Latest News

US Pharma and Biotech Summit 2024: Artificial Intelligence and Machine Learning Through the Eyes of the FDA
US Pharma and Biotech Summit 2024: Artificial Intelligence and Machine Learning Through the Eyes of the FDA

May 16th 2024

Soft Landing, Hard Problems
US Pharma and Biotech Summit 2024: The View from Investors

May 16th 2024

Image credit: AbudanceGuy | stock.adobe.com
FDA Grants Accelerated Approval to Breyanzi for Relapsed or Refractory Follicular Lymphoma

May 16th 2024

Conference Coverage

View All
US Pharma and Biotech Summit 2024: Artificial Intelligence and Machine Learning Through the Eyes of the FDA
US Pharma and Biotech Summit 2024: Artificial Intelligence and Machine Learning Through the Eyes of the FDA

May 16th 2024

Soft Landing, Hard Problems
US Pharma and Biotech Summit 2024: The View from Investors

May 16th 2024

Image credit: Design Cells | stock.adobe.com
Novartis' Lutathera Shows Significant Survival Benefit as First-Line Treatment for GEP-NETs

January 19th 2024

Eisai
Eisai To Present New Data For Gastrointestinal Cancer Research at ASCO GI 2024

January 17th 2024

Latest Videos
Podcasts

All News